Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 485-490

  Pancholy, Samir B ^a   Sharma, Parikshit S ^a   Pancholy, Dipti S ^a   Patel, Tejas M ^b   Callans, David J ^c   Marchlinski, Francis E ^c  

^a Wright Center for Graduate Medical Center   (United States)

^b Seth NHL Municipal Medical College   (India)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; EMBOLISM; EMBOLISM PREVENTION; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; SYSTEMIC EMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STROKE; WORLD HEALTH;

EID: 84892576626     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.035     Document Type: Article

References (24)

1. P.A. Wolf, E.J. Benjamin, A.J. Belanger, W.B. Kannel, D. Levy, and R.B. D'Agostino Secular trends in the prevalence of atrial fibrillation: The Framingham Study Am Heart J 131 1984 790 795
2. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study J Am Med Assoc 271 1994 840 844
3. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution and gender of patients with atrial fibrillation Arch Intern Med 155 1995 469 473
4. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study J Am Med Assoc 285 2001 2370 2375
5. R.G. Hart, L.A. Pearce, R. McBride, R.M. Rothbart, and R.W. Asinger Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) investigators Stroke 30 1999 1223 1229
6. T.J. Wang, J.M. Massaro, D. Levy, R.S. Vasan, P.A. Wolf, R.B. D'Agostino, M.G. Larson, W.B. Kannel, and E.J. Benjamin A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study J Am Med Assoc 290 2003 1049 1056
7. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
8. J.B. Olesen, G.Y. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, J. Lindhardsen, C. Selmer, O. Ahlehoff, A.M. Olsen, G.H. Gislason, and C. Torp-Pedersen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study Br Med J 342 2011 d124
9. M.C. Fang, D.E. Singer, Y. Chang, E.M. Hylek, L.E. Henault, N.G. Jensvold, and A.S. Go Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study Circulation 112 2005 1687 1691
10. L. Friberg, L. Benson, M. Rosenqvist, and G.Y. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study Br Med J 344 2012 e3522
11. M. Hughes, G.Y. Lip, Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, and National Institute for Health and Clinical Excellence Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data ThrombHaemost 99 2008 295 304
12. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
13. F. Scaglione New oral anticoagulants: comparative pharmacology with vitamin K antagonists ClinPharmacokinet 52 2013 69 82
14. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P. Gøtzsche, J. Ioannidis, M. Clarke, P. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
15. Mardi Gomberg-Maitland, Nanette K. Wenger, Jan Feyzi, M. Lengyel, A.S. Volgman, P. Petersen, L. Frison, and J.L. Halperin Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials Eur Heart J 27 2006 1947 1953
16. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
17. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, H.R. Al-Khalidi, J. Ansell, D. Atar, A. Avezum, M.C. Bahit, R. Diaz, J.D. Easton, J.A. Ezekowitz, G. Flaker, D. Garcia, M. Geraldes, B.J. Gersh, S. Golitsyn, S. Goto, A.G. Hermosillo, S.H. Hohnloser, J. Horowitz, P. Mohan, P. Jansky, B.S. Lewis, J.L. Lopez-Sendon, P. Pais, A. Parkhomenko, F.W. Verheugt, J. Zhu, L. Wallentin ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
18. Jonathan Mant, FD Richard Hobbs, Kate Fletcher, Andrea Roalfe, David Fitzmaurice, Gregory YH. Lip, Ellen Murray on behalf of the BAFTA investigators and the Midland Research Practices Network (MidReC) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
19. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, R.M. Califf ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
20. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, S. Golitsyn, G. Flaker, A. Avezum, S.H. Hohnloser, R. Diaz, M. Talajic, J. Zhu, P. Pais, A. Budaj, A. Parkhomenko, P. Jansky, P. Commerford, R.S. Tan, K.H. Sim, B.S. Lewis, W. Van Mieghem, G.Y. Lip, J.H. Kim, F. Lanas-Zanetti, A. Gonzalez-Hermosillo, A.L. Dans, M. Munawar, M. O'Donnell, J. Lawrence, G. Lewis, R. Afzal, S. Yusuf AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
21. Comprehensive meta-analysis Version 2.0 (Biostat, Englewood, new Jersey).
22. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis ThrombHaemost 3 2005 692 694
23. D. Poli, E. Antonucci, E. Grifoni, R. Abbate, G.F. Gensini, and D. Prisco Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment ThrombHaemost 101 2009 938 942
24. D.G. Sherman, S.G. Kim, B.S. Boop, S.D. Corley, J.P. Dimarco, R.G. Hart, L.J. Haywood, K. Hoyte, E.S. Kaufman, M.H. Kim, E. Nasco, A.L. Waldo National Heart, Lung, and Blood Institute AFFIRM investigators Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191